Group One Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$452K Buy
30,040
+12,356
+70% +$297K ﹤0.01% 3494
2026
Q2
$590K Sell
17,684
-122,482
-87% -$3.04M ﹤0.01% 3337
2026
Q1
$2.94M Buy
140,166
+116,958
+504% +$2.63M 0.01% 1721
2025
Q4
$534K Buy
+23,208
New +$763K ﹤0.01% 3436
2025
Q3
– Sell
-5,559
Closed -$167K – 9012
2025
Q2
$202K Buy
+5,559
New +$200K ﹤0.01% 4333
2025
Q1
– Sell
-3,610
Closed -$150K – 8240
2024
Q4
$152K Sell
3,610
-6,349
-64% -$315K ﹤0.01% 4154
2024
Q3
$553K Sell
9,959
-511
-5% -$26K ﹤0.01% 2776
2024
Q2
$430K Buy
10,470
+1,335
+15% +$57K ﹤0.01% 2704
2024
Q1
$427K Buy
9,135
+2,851
+45% +$134K ﹤0.01% 2890
2023
Q4
$301K Buy
6,284
+591
+10% +$22.9K ﹤0.01% 3503
2023
Q3
$203K Buy
+5,693
New +$226K ﹤0.01% 3785
2023
Q2
– Sell
-8,648
Closed -$401K – 8110
2023
Q1
$347K Buy
+8,648
New +$371K ﹤0.01% 3125
2022
Q1
– Sell
-130
Closed -$11K – 8563
2021
Q4
$11K Buy
130
+100
+333% +$8.14K ﹤0.01% 7314
2021
Q3
$3K Sell
30
-871
-97% -$78.7K ﹤0.01% 7882
2021
Q2
$86K Buy
901
+804
+829% +$83.8K ﹤0.01% 6106
2021
Q1
$11K Buy
+97
New +$13.2K ﹤0.01% 7022
2020
Q3
– Sell
-101
Closed -$8K – 6474
2020
Q2
$8K Sell
101
-1,077
-91% -$71.3K ﹤0.01% 5223
2020
Q1
$52K Buy
1,178
+875
+289% +$45.4K ﹤0.01% 3689
2019
Q4
$13K Buy
303
+251
+483% +$10.4K ﹤0.01% 4519
2019
Q3
$2K Hold
52
– – ﹤0.01% 4923
2019
Q2
$3K Buy
+52
New +$3.31K ﹤0.01% 4704
2019
Q1
– Sell
-7
Closed -$400 – 5271
2018
Q4
$0 Buy
+7
New +$383 ﹤0.01% 5313
2018
Q3
– Sell
-829
Closed -$67.4K – 5539
2018
Q2
$64K Buy
+829
New +$53.5K ﹤0.01% 3821
2017
Q1
– Sell
-1,009
Closed -$76.9K – 4933
2016
Q4
$71K Buy
1,009
+573
+131% +$40.7K ﹤0.01% 3044
2016
Q3
$31K Sell
436
-5,689
-93% -$363K ﹤0.01% 3600
2016
Q2
$300K Buy
6,125
+3,151
+106% +$204K ﹤0.01% 2122
2016
Q1
$188K Buy
+2,974
New +$195K ﹤0.01% 2360
2015
Q1
– Sell
-716
Closed -$39.8K – 5095
2014
Q4
$31K Sell
716
-439
-38% -$20.1K ﹤0.01% 3707
2014
Q3
$65K Buy
1,155
+755
+189% +$38K ﹤0.01% 3351
2014
Q2
$18K Buy
+400
New +$16.5K ﹤0.01% 4232

Other funds holding RARE

Group One Trading's RARE Position: Q3 2026 in Review

Group One Trading increased its Ultragenyx Pharmaceutical (RARE) stake by 70% in Q3 2026, buying an estimated $297K and bringing the position to 30,040 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #3494.

Group One Trading first reported a position in RARE in Q2 2014 and has held it in 30 quarters since. The position peaked at $2.94M in Q1 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Group One Trading held 30,040 shares of Ultragenyx Pharmaceutical worth $452K as of Q3 2026.
  • Group One Trading bought 12,356 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $297K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3494 holding.
  • Group One Trading first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 30 quarters since.
  • Group One Trading's Ultragenyx Pharmaceutical position peaked at $2.94M in Q1 2026.
  • 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.